Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
20.85
+0.23 (1.12%)
May 6, 2026, 4:00 PM EDT - Market closed
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $486.48 million as of May 7, 2026. Its market cap has increased by 258.09% in one year.
Market Cap
486.48M
Enterprise Value
290.26M
1-Year Change
258.09%
Ranking
Category
Stock Price
$20.85
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $486.48M, a decrease of -88.22%. That is a compound annual growth rate of -35.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 486.48M | -25.60% |
| Dec 31, 2025 | 653.89M | 249.70% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 504.89M |
| Neurogene | 504.86M |
| Upstream Bio | 500.12M |
| Assembly Biosciences | 498.87M |
| XOMA Royalty | 496.41M |
| Rigel Pharmaceuticals | 494.06M |
| Ocugen | 492.54M |
| ADC Therapeutics | 490.96M |